This interactive presentation will provide you with an opportunity to learn more about how can manufacturers meet global patient demand for access to medicines prior to approval. This will also discuss some of the methods that orphan drug manufacturers can do to partner with governments to bring orphan drugs to the market. R&D strategies to be implemented to accelerate market access for orphan drugs will also be explore. And how can patient, governments and orphan drug companies help support each other’s initiative to provide market access to patients?
WHO’S IT FOR
This workshop will be extremely beneficial to those individuals involve in development, commercialization and market access of orphan drugs. Project Managers and Executives in Pharma/Biotech companies, consultancy, Patient Advocacy, interested in knowing how to successfully launch an orphan drug.
This interactive presentation will provide you with an opportunity to learn more about how EAP’s provide pre -launch access for drugs in advance of their Marketing Authorization (MA) for patients with life- threatening conditions and no approved treatment options. Best practices in EAP planning, Set-Up and management, and provide information on current regulatory changes
WHO’S IT FOR
This workshop will be extremely beneficial to those individuals considering an EAP as part of their drug development strategy. Project Managers and Executives in Pharma/Biotech/Advocacy interested in knowing how to set-up an Early Access Program.